Composition, efficacy, and safety of S/D-treated plasma
- 22 July 2003
- journal article
- website
- Published by Wiley in Transfusion
- Vol. 43 (8) , 1176-1178
- https://doi.org/10.1046/j.1537-2995.2003.00461.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Fibrinolysis During Liver Transplant and Use of Solvent/Detergent Virus-Inactivated Plasma (ESDEP??/Octaplas??)Anesthesia & Analgesia, 2003
- Guidelines for assessing appropriateness of pediatric transfusionTransfusion, 2002
- Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacyThrombosis Research, 2002
- Fibrinolysis During Liver Transplantation Is Enhanced by Using Solvent/Detergent Virus-Inactivated Plasma (ESDEP®)Anesthesia & Analgesia, 2002
- Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: Is its decreased protein S activity clinically related to their development of deep venous thromboses?Journal of Clinical Apheresis, 2000
- α2-Plasmin inhibitor is among acute phase reactantsThrombosis Research, 1980